Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Peptide Therapeutics Market Grown from 2024 to 2025?

In the past few years, the peptide therapeutics market has seen significant expansion. The market size, which was $45.15 billion in 2024, is expected to increase to $49.67 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.0%. The expansion during the historical period can be ascribed to the rising prevalence of chronic illnesses, enhanced comprehension of molecular biology, and the broadening use of peptides in oncology.

What Growth Rate Is Anticipated for the Peptide Therapeutics Market in the Coming Years?

Forecasted to experience rapid expansion in the next few years, the peptide therapeutics market is predicted to reach a valuation of $76.64 billion by 2029, with a compound annual growth rate (CAGR) of 11.5%. The anticipated growth in the forecast period is mainly due to the increasing demand for personalized medicine, widespread application in immunotherapy, improvements in peptide delivery systems, the emergence of peptide targets in infectious diseases, and a growing focus on rare diseases. Key trends forecasted to mark this period involve advancements in peptide synthesis technology, heightened investment and funding, focus on the safety of peptide drugs, market proliferation in emerging economies, and the incorporation of artificial intelligence (AI).

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

Who Are the Leading Companies in the Peptide Therapeutics Market?

Major companies operating in the peptide therapeutics market include Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.

What Are the Key Drivers of the Peptide Therapeutics Market?

The anticipated surge in chronic disease incidence is likely to fuel the expansion of the peptide therapeutics market. Chronic diseases are enduring illnesses that are usually incurable, but they can sometimes be cured and managed. Factors such as increased tobacco use, inadequate nutrition, lack of physical activity, and excessive alcohol consumption are contributing to the rise in chronic diseases. Peptide therapeutics play a crucial role in preventing and treating some chronic diseases. For example, the National Library of Medicine, a US-based institution, projected in January 2023 that by 2050, the number of individuals aged 50 and above in the US with at least one chronic disease would rise by 99.5%, equating to 142.66 million people. Thus, the escalating incidence of chronic diseases is predicted to stimulate the growth of the peptide therapeutics market in the projected years.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7216&type=smp

What Are the Key Market Segments in the Peptide Therapeutics Industry?

The peptide therapeutics market covered in this report is segmented –

1) By Type: Generic, Branded

2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal

3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

Subsegments:

1) By Generic: Generic Peptide Drugs, Biosimilars

2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides

What Are the Latest Trends in the Peptide Therapeutics Market?

Leading firms in the peptide therapeutics market are strategizing to stay competitive by introducing innovative solutions like cell culture process. This technique involves artificially cultivating cells outside their natural environment under regulated conditions, including the removal and maintenance of desirable cells from living tissue. For instance, Evonik Industries AG, a specialty chemicals company based in Germany, unveiled cQrex KC in June 2023. cQrex KC is a next-generation peptide for biopharma applications which enhances the cell culture process used in the creation of biological drugs. It provides cell culture process developers with the ability to enhance cystine supply and boost productivity. Moreover, cQrex KC aids in the development of vaccines, viral vectors and cell therapies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

What Are the Key Regional Markets in the Peptide Therapeutics Industry?

North America was the largest region in the peptide therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7216

This Report Delivers Insight On:

1. How big is the peptide therapeutics market, and how is it changing globally?

2. Who are the major companies in the peptide therapeutics market, and how are they performing?

3. What are the key opportunities and risks in the peptide therapeutics market right now?

4. Which products or customer segments are growing the most in the peptide therapeutics market?

5. What factors are helping or slowing down the growth of the peptide therapeutics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model